Viral infection-induced thrombosis is a rare entity. It is known to occur with infection by several strains of viruses that are associated with disease severity. The Epstein-Barr, human immunodeficiency, and H1N1 influenza A viruses are examples that can result in thrombosis.[@bib1], [@bib2], [@bib3] Consequently, with the current novel coronavirus (CoV) pandemic, knowledge of viral infection-induced thrombosis becomes even more important. The phenomenon of vascular thrombosis as described by Virchow involves changes in the vessel, blood flow, or fluid constituents.[@bib4] ^,^ [@bib5] Therefore, any factor that can alter the homeostatic mechanisms of these three components will predispose to thrombosis. Reports in the literature provide insight on changes predisposing an individual to thrombosis as a result of severe viral infections.[@bib6] ^,^ [@bib7]

The CoV is a beta coronavirus (enveloped single-stranded RNA virus), of which many symptoms of infection involve the respiratory and cardiac systems in patients requiring hospitalization.[@bib8] There is emerging evidence to support the trends of increased morbidity and mortality from CoV infection that occurs more frequently in older individuals with comorbidities.[@bib9] ^,^ [@bib10] Furthermore, in the older population with coexisting medical illnesses, the combination of severe infection with the CoV can result in an increased tendency for intra-arterial thrombosis.

In general, the symptoms of mesenteric or limb ischemia are nonspecific in a critically ill patient; as such, there may be a delay in the diagnosis. Further time elapses can be anticipated as infectious disease protocols are necessary when performing diagnostic investigations as well as endovascular or open surgical management in a CoV-positive patient. Any significant delay in the definitive management can result in limb loss, intra-abdominal catastrophe, or even death.

In conclusion, we wish to highlight the entity of viral infection-induced thrombosis and intra-arterial thrombosis in association with severe viral infections, especially in the CoV-positive patient. We wish to encourage our colleagues across all fields of specialty to have a high index of suspicion for signs of limb and mesenteric ischemia. The early diagnosis of these conditions has a tremendous influence on the success of treatment.
